BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 11422732)

  • 1. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
    Guan Y; Breyer MD
    Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J; Wagner JA
    Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of PPARs in the Transcriptional Control of Cellular Processes.
    Guan Y; Zhang Y; Breyer MD
    Drug News Perspect; 2002 Apr; 15(3):147-154. PubMed ID: 12677257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.
    Gilde AJ; Van Bilsen M
    Acta Physiol Scand; 2003 Aug; 178(4):425-34. PubMed ID: 12864748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARs and the kidney in metabolic syndrome.
    Ruan X; Zheng F; Guan Y
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PPAR family and its relationship to metabolic syndrome].
    Zhang XY; Chen LH; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion.
    Thuillier P; Anchiraico GJ; Nickel KP; Maldve RE; Gimenez-Conti I; Muga SJ; Liu KL; Fischer SM; Belury MA
    Mol Carcinog; 2000 Nov; 29(3):134-42. PubMed ID: 11108658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.
    Guan Y; Zhang Y; Davis L; Breyer MD
    Am J Physiol; 1997 Dec; 273(6):F1013-22. PubMed ID: 9435691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y
    J Am Soc Nephrol; 2004 Nov; 15(11):2801-15. PubMed ID: 15504933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney.
    Yang T; Michele DE; Park J; Smart AM; Lin Z; Brosius FC; Schnermann JB; Briggs JP
    Am J Physiol; 1999 Dec; 277(6):F966-73. PubMed ID: 10600944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PPARs and cell-cell or cell-extracellular matrix interactions].
    Murad H; Fiatte C; Brunner E; Huin-Schohn C; Schohn H; Bécuwe P; Domenjoud L; Dauça M
    Med Sci (Paris); 2007 May; 23(5):515-8. PubMed ID: 17502068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.